Loading organizations...
§ Private Profile · San Diego, CA, USA
Biopharmaceutical company developing curative treatments for chronic hepatitis B virus (HBV) infection in San Diego, California.
Chromis Therapeutics is a San Diego, California-based biopharmaceutical company focused on the research and development of curative treatments for chronic hepatitis B virus (HBV) infections. Operating within the broader biotechnology and healthcare sectors, the venture-funded enterprise concentrates its scientific efforts on engineering innovative therapeutic solutions designed to address this major global health challenge. To support its ongoing clinical research and drug discovery pipelines, the organization receives financial backing from specialized life sciences venture capital firms, notably including Torrey Pines Investment. The strategic direction and corporate governance of the firm are overseen by a board of directors that features recognized industry professionals, including Ronald Demuth and Jennifer Giottonini Cayer. While the exact founding year of the organization remains undisclosed, the biotechnology enterprise was established by scientific co-founders Nikolay Savchuk, who currently serves as the chairman, and Vadim Bichko.
Chromis Therapeutics has raised $3.0M across 1 funding round.
Chromis Therapeutics has raised $3.0M in total across 1 funding round.
Chromis Therapeutics has raised $3.0M in total across 1 funding round.
Chromis Therapeutics's investors include Torrey Pines Investment.
Chromis Therapeutics has raised $3.0M across 1 funding round. Most recently, it raised $3.0M Seed in February 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 26, 2016 | $3M Seed | Torrey Pines Investment | — | Announced |